Skip navigation

Calls to Action

Clinical Trials

Please use independent judgment and request references when considering any resource associated with diagnosis or treatment of autism or its associated medical conditions. The following information is solely for educational purposes, not medical advice. It is not a substitute for care by trained medical providers. Autism Speaks is not engaged in the practice of health care or the provision of health care advice or services. For specific advice about care and treatment, please consult your physician.

Horrigan Will Oversee the Organization’s Growing Agenda in Medicine Development, Medical Research and Training, and Clinical Trials Research to Address the Core and Associated Symptoms of Autism Spectrum Disorders

Autism Speaks has named Joseph Patrick Horrigan, M.D., FAACAP to the newly created position of assistant vice president, head of medica

October 13, 2011

New York, N.Y. (October 13, 2011) – Autism Speaks, North America’s largest autism science and advocacy organization, has named Joseph Patrick Horrigan, M.D., FAACAP to the newly created position of assistant vice president, head of medical research. He will be responsible for overseeing the organization’s expanding medical research and training portfolio, which is focused on medical treatments and clinical trials research with the goal of improving outcomes for individuals with autism spectrum disorders (ASD). Dr.

Many opportunities are available for families to participate in autism research. You can join a clinical trial, enroll in a research study, contribute to our rich genetic database or participate online by adding your family information to a research database. Nearly 90 percent of children with cancer are enrolled in clinical trials--contrasted with only 5 percent of children with autism. Your participation can make a difference in the lives of all who struggle with autism.

April 17, 2008

Neuropharm Group plc, sponsor of the Study of Fluoxetine in Autism (SOFIA) clinical trial, received "Fast Track" designation by the US Food and Drug Administration (FDA) last week, thereby affirming the urgent

need for medicines that target autism.

Archive
Autism Speaks, Science, Latest Research